SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances announcement of positive IOV-LUN-202 Phase 2 results in previously treated metastatic NSCLC and a webcast to discuss the data has driven attention, with traders focused on whether lifileucel could expand beyond melanoma and whether precision-based patient selection strengthens the case. The community is broadly enthusiastic, but speculation about improved response rates, an earlier FDA path, and a short squeeze remains unconfirmed pending detailed data.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabets quarterly results sparked a sharp selloff as investors focused on the earnings shortfall, negative free cash flow, and expectations for significantly higher AI infrastructure spending, despite rapid Google Cloud growth. Traders are split between viewing the drop as a buying opportunity and worrying that capex, weaker advertising and search trends, and uncertain AI returns could pressure the business.

Alphabet Inc - Ordinary Shares - Class C

Alphabets earnings disappointment and heavy AI infrastructure spending, which weighed on profits and cash flow despite strong Google Cloud growth, are driving the discussion. Traders are split between viewing the selloff as an overreaction and worrying that rising costs, slowing search growth, and AI competition could undermine returns.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts quarterly results beat expectations, with accelerating Azure growth and a stronger outlook; traders also welcomed capital spending coming in below expectations. The initial bullish reaction faced a sell-the-news counterpoint, as some debated whether AI investment can translate into durable cash flow and the shares gave back part of their after-hours gains.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Reports that Marvell is in advanced talks to acquire Lumentum have driven attention, with traders debating whether the reported deal will materialize and how Marvell would finance it. The potential tie-up is seen as a strategic move in AI data-center optics, but no agreement is final.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNows mixed quarterly resultsan earnings miss and softer forward contract-growth guidance despite revenue growth and a raised AI sales targettriggered a sharp selloff. Traders are divided between concerns about slowing software growth and AI disruption, and buyers who view the drop as an overreaction to strong AI demand and business momentum.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS said its Phase 3 REGAL trial of the AML vaccine GPS reached the prespecified 80th event, triggering final analysis ahead of topline results expected this quarter. The stocks sharp decline after the milestone has fueled debate: some traders view it as a sell-the-news reaction before a binary data readout, while others warn the trials efficacy remains uncertain.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Vikings Q3 results and conference-call comments have focused attention on VK2735s commercialization timeline, with the CEOs estimate of roughly two and a half years to launch prompting criticism that the company is moving too slowly. Investors are also debating cash burn and dilution risk, and whether Viking will pursue a partnership or commercialize independently; bullish voices point to the obesity drugs ongoing Phase 3 program and future data as reasons for patience.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendys shares jumped on a Trian-led groups proposal to take the company private. Traders largely view the offer as too low and anticipate board resistance or a higher bid, while others warn the proposal could cap gains or fall through; short-squeeze speculation is also common.

Fortinet, Inc. provides cybersecurity solutions to a variety of businesses, such as enterprises, communication service providers, government organizations, and small to medium-sized businesses. Its product portfolio includes network security, secure access service edge, enterprise networking, security operations, application security, and operational technology. The company was founded by Ken Xie and Michael Xie in November 2000 and is headquartered in Sunnyvale, CA.

Fortinet Inc

Fortinets sharp post-earnings selloff is dominating discussion: despite an EPS and revenue beat and higher full-year revenue guidance, traders are focused on a reduced service-revenue outlook and signs of slowing growth amid a high valuation. Bulls call the drop an overreaction to otherwise solid results, while bears see the forecast and growth concerns as justification; the decline is also weighing on cybersecurity peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Quanterix To Report Third Quarter 2026 Financial Results on November 9, 2026

Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that it will host a conference call on Monday, November 9, 2026, at 8:30 AM ET, to discuss its third quarter 2026 financial results. Quanterix will issue a press release regarding its third quarter...

Quanterix and Innovita Expand IVD Access in China with National Medical Products Administration Approvals

Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, and Innovita Biological Technology Co., Ltd. (SSE: 688253.SH), a leading in vitro diagnostics company in China, today announced regulatory approvals that advance access to the Quanterix SIMOA technology and...

Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026

Quanterix Corporation (NASDAQ: QTRX) today reported significant progress on the Content Innovation Engine it introduced at the American Association for Cancer Research (AACR) Annual Meeting 2026, highlighting new updates at the European Society for Spatial Biology (ESSB) September 28-October 1...

Quanterix Names Dr. Yuri Fesko Chief Medical Officer

Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that accomplished physician executive Dr. Yuri Fesko has been appointed Chief Medical Officer of the company. In this new role, he will provide medical and clinical leadership across Quanterix...

Quanterix (QTRX) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 32.0% to $0.41 during Friday's after-market session. The company's market cap stands at $4.9 million.
Quanterix (NASDAQ:QTRX) shares increased byread more...

Quanterix Q2 Earnings Call Highlights

Quanterix Names Jim Gute Chief Commercial Officer

Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that seasoned healthcare executive Jim Gute has been appointed Chief Commercial Officer of the company. In this role, he will lead a re-acceleration of growth within the companys commercial...

Quanterix Releases Financial Results for the Second Quarter of 2026

Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, today announced financial results for the second quarter ended June 30, 2026. We made meaningful progress in the second quarter, including strengthening our leadership team and preserving cash better than planned...

Quanterix To Participate in Canaccord Genuity Capital Markets 46th Annual Growth Conference on August 11-12

Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that senior management will participate in the Canaccord Genuity Capital Markets 46th Annual Growth Conference at the Intercontinental Hotel in Boston on August 11-12, 2026. Chief Executive Officer...

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Quanterix Corp

TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today 

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Trinity shares climbed after the company launched Trinovium, a subsidiary focused on liquid-cooling solutions for AI data centers.</li><li>Quanterix gained after new CFO Jason Faessler officially took office, completing a broader leadership overhaul.&nbsp;</li><li>Recon posted the biggest after-hours gain after rebounding from a record low of $0.43.&nbsp;</li></ul>Trinity Biotech (TRIB), Recon Technology (RCON), and Quanterix Corp. (QTRX) each recorded double-digit advances&nbsp;in after-hours trading Tuesday as&nbsp;new growth opportunities, management changes, or technical trading setups stoked investors’ interest.&nbsp;&nbsp;<h2 class="st-heading-2">TRIB Enters AI Data Center Cooling Market With Trinovium Launch&nbsp;</h2>Trinity shares rose after the company launched Trinovium, a new subsidiary focused on developing liquid-cooling solutions for AI data centers. The move comes as data center operators turn to liquid cooling to handle the heat produced by advanced chips and AI systems.&nbsp;The initiative will utilize Trinity’s established manufacturing network in the U.S. and Europe, along with its experience producing high-purity fluids for healthcare applications.Rather than building entirely new production facilities, Trinity plans to repurpose part of its current manufacturing capacity. The company said its facilities already produce large volumes of specialized fluids annually, allowing it to enter the market without substantial additional capital investment and to improve returns from existing operations.Trinovium's first offering is a direct-to-chip cooling fluid designed to support equipment protection, fluid stability, and high levels of purity.&nbsp;<a href="https://stocktwits.com/symbol/TRIB">Trinity Biotech stock</a> traded over 16% higher overnight. On Stocktwits, retail sentiment around the stock jumped to ‘extremely bullish’ from ‘bearish’ territory the previous day.&nbsp;<h2 class="st-heading-2">QTRX Completes Leadership Transition</h2>Quanterix rose after the company’s newly appointed CFO, Jason Faessler, officially assumed the role on Tuesday. The transition follows broader leadership changes, including the appointment of Geoff Albrecht to oversee the diagnostics segment.Investors saw the leadership changes as a way to bring more stability to the company as it continues developing blood tests for neurological diseases, including Alzheimer's.&nbsp;Despite advances in its Alzheimer's testing programs and merger-related cost savings, Quanterix stock has struggled to regain traction, losing roughly half its value in the last 12 months.<a href="https://stocktwits.com/symbol/QTRX">Quanterix stock</a> traded nearly 6% higher overnight. Retail sentiment around the stock remained in ‘neutral’ territory.&nbsp;&nbsp;<h2 class="st-heading-2">RCON Benefits From Technical Rebound</h2>Recon Technology delivered the strongest gain of the group after falling sharply during the regular trading session. The stock hit a record low of $0.43 earlier in the day before buyers returned in after-hours trading.The stock's rebound appears to be driven by speculative buying and investors closing short positions.&nbsp;Recon has seen its shares plunge 83% in the last 12 months. One of the biggest pressures on the stock has been the company’s capital-raising activity. Earlier this year, Recon filed a large mixed-shelf registration that raised expectations for future stock issuance. Those concerns intensified after the company completed an $18 million private placement transaction in April.<a href="https://stocktwits.com/symbol/RCON">Recon Technology stock</a> traded over 27% higher overnight. Retail sentiment around the stock remained in ‘bearish’ territory.&nbsp;So far this year, QTRX and TRIB stocks declined 49% and 55%, respectively, while RCON stock plunged 72%. Year-to-date.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/cdw-stock-jumps-nearly-6-percent-morgan-stanley-bullish-it-play/cZKwB8FR7as">CDW Stock Jumps Nearly 6% — Why Morgan Stanley Is Growing More Optimistic On This IT Play</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Exterior shows Quanterix offices in Lexington.

Trinity Biotech (TRIB), Recon Technology (RCON), and Quanterix Corp. (QTRX) each recorded double-digit advances&nbsp;in after-hours trading Tuesday as&nbsp;new growth opportunities, management changes, or technical trading setups stoked investors’ interes

The small-cap stocks surged between 6% and 27% after hours on Tuesday. 


Recon Technology Ltd - Ordinary Shares - Class A

Trinity Biotech plc

Yes, the bottom is in

No, more downside ahead

Too early to tell

Depends on the stock

Neocloud stocks like $NBIS, $CRWV, $IREN, and $APLD are rebounding after a brutal October. Have they bottomed?

Stocktwits

Nebius Group N.V. 

CoreWeave Inc

IREN Limited

Applied Digital Corporation

 are rebounding after a brutal October. Have they bottomed?

Stocktwits Polls

$QTRX I am holding onto my short until the bloodbath expected after the Q3 report. We all know this will post big losses and cash burn. Other criticism as below. The market will hate it.

Feed

News

Sentiment

Earnings

Fundamentals

Info

QTRX Quanterix Corp

Fundamentals

Latest QTRX News